Vaxcyte (NASDAQ:PCVX) EVP Sells $79,399.68 in Stock
Market Beat·- Vaxcyte, Inc. Executive Vice President Jim Wassil sold 1,334 shares of stock for $79,399.68 on September 9th to cover tax withholding obligations. - The transaction left the executive with 145,435 shares valued at $8,656,291.20, representing a 0.91% decrease in his position. - The company maintains a market capitalization of $8.86 billion and a moderate buy consensus rating among analysts.Alyeska Investment Group L.P. Cuts Holdings in Vaxcyte, Inc. $PCVX
Market Beat·- Alyeska Investment Group L.P. reduced its stake in Vaxcyte, Inc. by 16.8% during the second quarter, owning 362,272 shares valued at $21,059,000. - Vaxcyte reported a quarterly loss of ($1.97) per share for the period ending in August, outperforming the consensus estimate of ($2.06). - Institutional investors and company insiders collectively adjusted their positions, with insiders selling 118,396 shares worth $6,459,390 over the last quarter.